SEATTLE--(BUSINESS WIRE)--Animal and human healthcare thought leaders gathered in Seattle on Wednesday, December 11, for the first annual “Translational and Comparative Research Summit.” The Summit raised awareness in the medical, research and investment communities about species-spanning approaches to healthcare, which are leading to breakthrough therapies and new standards of care.
“One in three people, one in four dogs and one in five cats will develop cancer in their lifetime,” said summit speaker John Payne, chairman of the American Humane Association. “Animals and humans share many of the same diseases, and there is much to be learned from animal healthcare that can be translated to human healthcare, resulting in new and cost effective therapies for human diseases.”
“There are many chronic diseases that affect humans and animals such as cancer, heart disease, kidney disease, diabetes, obesity, asthma, arthritis and orthopedic diseases,” noted Dean of the College of Veterinary Medicine at Kansas State University Dr. Ralph Richardson.
The Summit speakers called for organized dialogue between physicians and veterinarians, to build on common pools of knowledge in areas such as physiology, pathology and epidemiology, embracing “One Health” and identifying mutual benefits for animals and human.
The Summit keynote speaker was Dr. Barbara Natterson-Horowitz, author of Zoobiquity: The Astonishing Connection Between Human and Animal Health. Other featured speakers included Dr. Gregory Ogilvie, director of CVS-Angel Care Cancer Centers and professor of Veterinary Oncology at University of California San Diego, Moores Cancer Center; Dr. Bryan Slinker, professor and dean of the College of Veterinary Medicine at Washington State University, which includes the new Paul G. Allen School for Global Animal Health; Dr. Santosh Kesari, chief of Neuro-Oncology at University of California San Diego, Moores Cancer Center; and Dr. Michael Salgaller, vice president at The Conafay Group in Washington D.C.
The Summit was sponsored by Nativis Inc., a Seattle-based life sciences company, DLA Piper, Silicon Valley Bank and the Washington Biotechnology and Biomedical Association.